Use of a T-cell-based test for detection of tuberculosis infection among immunocompromised patients

European Respiratory Journal

Volumn 28, Issue 1, 2006, Pages 31-34

  Piana, F ^a,b   Codecasa, L R ^b   Cavallerio, P ^a   Ferrarese, M ^b   Migliori, G B ^c   Barbarano, L ^b   Morra, E ^b   Cirillo, Daniela M ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b OSPEDALE NIGUARDA CA GRANDA   (Italy)

^c IRCCS   (Italy)

Author keywords

Contact tracing; Haematology; Interferon ; T SPOT.TM ; Tuberculosis

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; ISONIAZID; TUBERCULIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CONTACT EXAMINATION; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HODGKIN DISEASE; HOSPITAL INFECTION; HUMAN; IMMUNE DEFICIENCY; INTERMETHOD COMPARISON; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; MYCOBACTERIUM TUBERCULOSIS; MYELODYSPLASIA; NONHODGKIN LYMPHOMA; PREVALENCE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SPUTUM SMEAR; T LYMPHOCYTE; TUBERCULIN TEST;

AGED; AGED, 80 AND OVER; FEMALE; HEMATOLOGIC TESTS; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; NEOPLASMS; REPRODUCIBILITY OF RESULTS; T-LYMPHOCYTES; TUBERCULIN TEST; TUBERCULOSIS;

EID: 33750949663     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.06.00110205     Document Type: Article

References (24)

1. American Thoracic Society, Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000; 161: S221-S247.
2. Centers for Disease Control and Prevention. Screening for tuberculosis infection in high-risk populations. MMWR Morb Mortal Wkly Rep 1995; 44: 1-42.
3. Huebner RE, Schein MF, Bass JB. The tuberculin skin test. Clin Infect Dis 1993; 17: 968-975.
4. Pesanti EL. The negative tuberculin test. Tuberculin, HIV, and anergy panels. Am J Respir Crit Care Med 1994; 149: 1699-1709.
5. Dheda K, Udwadia ZF, Huggett JF, Johnson MA, Rook GAW. Utility of the antigen-specific interferon-γ assay for the management of tuberculosis. Curr Opin Pulm Med 2005; 11: 195-202.
6. Mazurek GH, LoBue PA, Daley CL, et al. Comparison of a whole-blood interferon γ assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection. JAMA 2001; 286: 1740-1747.
7. Meier T, Eulenbruch HP, Wrighton-Smith P, Enders G, Regnath T. Sensitivity of a new commercial enzyme-linked immunospot assay (T SPOT-TB) for diagnosis of tuberculosis in clinical practice. Eur J Clin Microbiol Infect Dis 2005; 24: 529-536.
8. Italian Ministry of Health. Guidelines for Tuberculosis Control. Article 115. Decree-Law March 31, 1998 No. 112. Rome, Italian Ministry of Health, 1998.
9. Moro ML, Malfait P, Salamina G, D'Amato S. Tuberculosis in Italy: available data and open questions. Epidemiol Prev 1999; 23: 27-36.
10. Lalvani A, Pathan AA, Durkan H, et al. Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Lancet 2001; 357: 2017-2021.
11. Ewer K, Deeks J, Alvarez L, et al. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 2003; 361: 1168-1173.
12. Richeldi L, Ewer K, Losi M, et al. T cell-based tracking of multidrug resistant tuberculosis infection after brief exposure. Am J Respir Crit Care Med 2004; 170: 288-295.
13. Shams H, Weis SE, Klucar P, et al. Enzyme-linked immunospot and tuberculin skin testing to detect latent tuberculosis infection. Am J Respir Crit Care Med 2005; 172: 1161-1168.
14. Zellweger JP, Zellweger A, Ansermet S, de Senarclens B, Wrighton-Smith P. Contact tracing using a new T-cell-based test: better correlation with tuberculosis exposure than the tuberculin skin test. Int J Tuberc Lung Dis 2005; 9: 1242-1247.
15. Lalvani A, Pathan AA, McShane H, et al. Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Am J Respir Crit Care Med 2001; 163: 824-828.
16. Chapman AL, Munkanta M, Wilkinson KA, et al. Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells. AIDS 2002; 16: 2285-2293.
17. Richeldi L, Ewer K, Losi M, et al. Early diagnosis of subclinical multidrug-resistant tuberculosis. Ann Intern Med 2004; 140: 709-713.
18. Liebeschuetz S, Bamber S, Ewer K, Deeks J, Pathan AA, Lalvani A. Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study. Lancet 2004; 364: 2196-2203.
19. Behr MA, Wilson MA, Gill WP, et al. Comparative genomics of BCG vaccines by whole-genome DNA micro-array. Science 1999; 284: 1520-1523.
20. Andersen P, Munk ME, Pollock JM, Doherty TM. Specific immune-based diagnosis of tuberculosis. Lancet 2000; 356: 1099-1104.
21. Horsburgh R. Priorities for the treatment of latent tuberculosis infection in the United States. N Engl J Med 2004; 350: 2060-2070.
22. Pai M, Lewinsohn DM. Interferon-γ assays for tuberculosis, is anergy the Achille's heel? Am J Respir Crit Care Med 2005; 172: 519-521.
23. Ferrara G, Losi M, Meacci M, et al. Routine hospital use of a new commercial whole blood interferon-γ assay for tuberculosis infection. Am J Respir Crit Care Med 2005; 172: 631-635.
24. Dheda K, Lalvani A, Miller RF, et al. Performance of a T-cell-based diagnostic test for tuberculosis infection in HIV-infected individuals is independent of CD4 cell count. AIDS 2005; 19: 2038-2041.